CIDPUSA.ORG

 
Home
Diagnosis
Treatment
Pathology
Women Heart attack
Women risk diseases
Women stroke Risk
Services Page
Diet
Women ER delay
Inner Ear Disease
Women Killer Disease
Autoimmune diseases
Natural Makeup
Personality
Hair & Chemicals

Avoid headaches with IVIg

Cholesterol drugs & Bleeding

Learn about Self

Myofacial Pain

Lymes Disease & CIDP

Immunoglobulin's

Mammogram

Kidney therapy

Alopecia

AIDS Cause

Vitamin C helps stop Cancer

Daily vinegar for health

Best Fat Lowering diet.

Fish helps Memory

Best Way to cook rice

Limbic encephalitis

Agent Orange causes Cancer

Blood injection therapy

Statin Induced Dementia

Estrogens affect the memory

Fosamax

Health news

PulsedMagnetic

 

 

 

.

SpecialGoogleHealth Search
Alternative medical treatments read our e-book 

  • In the original regimen, cyclophosphamide was continued for a full year beyond that point at which the disease was in remission. The dose of cyclophosphamide was then decreased gradually and eventually stopped. In more recent treatment approaches, however, cyclophosphamide is given until remission and then switched to another medicine such as methotrexate or azathioprine (discussed below).

    Cyclophosphamide is a powerful medicine that keeps the immune system from working normally. Doctors must monitor their patients carefully and perform blood tests frequently. Cyclophosphamide can cause an increased risk of infection, bone marrow suppression (lowering of blood counts), sterility, hemorrhagic cystitis (bleeding from the bladder), bladder cancer, as well as other serious side effects.


    Methotrexate
    Methotrexate has been studied at NIH for the treatment of Wegener's granulomatosis since 1990. In people with active, but not immediately life threatening, Wegener's granulomatosis, methotrexate has been used in combination with prednisone to bring about remission. It also is used to maintain remission after a person has initially received cyclophosphamide. Methotrexate is usually given for 1 to 2 years, after which time if people stay in remission, it is decreased and stopped.

    Methotrexate is given once a week usually by mouth, but occasionally as an injection under the skin or in the muscle. People taking methotrexate need to have regular blood work to monitor their response and to watch for side effects.



    The side effects of methotrexate include infection, lowering of the blood counts, nausea, soreness and ulceration of the mouth lining, irritation of the lungs (pneumonitis), and inflammation and scarring of the liver. People taking methotrexate cannot drink alcoholic beverages. Methotrexate cannot be given to people who have poor kidney function or who have underlying liver disease such as hepatitis.

    Azathioprine
    Azathioprine (also called Imuran) is used primarily to maintain remission in people who have initially been treated and gone into remission with cyclophosphamide. It is taken once a day by mouth. Similar to methotrexate, it is usually given for 1 to 2 years after which time the dosage is lowered until it is stopped.

    The side effects of azathioprine include infection, lowering of the blood counts, and rarely an allergic type reaction. In people who receive azathioprine to prevent rejection of a transplanted organ, there has been a suggestion of an increased risk of blood cancers (leukemia and lymphoma) but it is not clear whether this risk exists in other situations. People with poor kidney function or liver disease can take azathioprine.

    Other medicines
    During the course of treating Wegener's granulomatosis, doctors often give their patients other medicines to prevent medicine-related side effects. These include

    Trimethoprim/sulfamethoxazole (also called bactrim or septra) is given three times a week to prevent Pneumocystis carinii infection (a lung infection)
    A medicine regimen is often given to prevent prednisone-related bone loss (osteoporosis)
    Folic acid or folinic acid (also called leucovorin) are often given to people taking methotrexate

  •